Shares of Kimberly-Clark (KMB) were rising 1.4% just after 3 on Tuesday, while Avon Products (AVP) was down 1.4%, a neat symmetry that reflects BMO Capital Markets��take on the two companies.
Analysts Connie Maneaty and Patrick Trucchio upgraded Kimberly to Outperform today, while downgraded Avon to Underperform.
First, the good news: Maneaty and Trucchio write that they see Kimberly-Clark�� gross margin widening by 280 basis points in the second half of next year, thanks to lower commodity costs. This leads them to raise their earnings per share estimates by 25 cents and 30 cents for 2015 and 2016, respectively, and they also boosted their target price by $9 to $125.
Highlights from the note:
We think KMB will be perceived as the safest of the multinationals. Its sales outside the US are about 55% of total; this compares to 65%-70% for Procter & Gamble (PG) and Coty (COTY) and 80%-90% for Colgate (CL), Avon and Tupperware (TUP). In general, its risk to the most volatile currencies is below average (its exposure to Eastern Europe is less than 2% of sales), though it is still translating results in Venezuela (about 3% of sales and profit) at the official rate of 6.3 VEF/$ (the parallel rate just hit 175 VEF/$) and Argentina (also 3% of sales) may devalue again. The cost of important raw materials has started to weaken; as they follow oil�� decline they could boost gross margins in 2H15. Of note, polypropylene and natural gas are off 17% 4Q-to-date; pulp prices, while not declining much, seem manageable.
Hot Machinery Companies To Invest In Right Now: Elite Pharmaceuticals Inc (ELTP)
Elite Pharmaceuticals, Inc. (Elite), incorporated on October 1, 1997, is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals. Elite has four products: Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules and Hydromorphone Hydrochloride 8 milligram tablets. During the fiscal years ended March 31, 2012 (Fiscal 2011), the Company manufactured and sold Lodrane 24 and Lodrane 24D (the Lodrane Extended Release Products).
The Company has a pipeline of additional generic drug candidates under active development, including, without limitation, ELI-154, a once-a-day oxycodone product and ELI-216, an abuse resistant oxycodone product which utilizes the Company�� propriety formulation for abuse resistant products utilizing the pharmacological approach (Elite�� Abuse Resistant Technology). ECR Pharmaceuticals (ECR), a wholly owned subsidiary of Hi-Tech Pharmacal, Inc. and the owner and marketer of the Lodrane Extended Release Products. Elite also purchased from Mikah Pharma LLC, an approved Abbreviated New Drug Application (ANDA) for Naltrexone 50 milligram tablets.
For ELI-154, Elite has developed a once-daily oxycodone formulation using its technology. An investigational new drug application (IND) has been filed and Elite has completed two pharmacokinetic studies in healthy subjects that compared blood levels of oxycodone from dosing ELI-154 and the twice-a-day product that is on the market, OxyContin marketed in the United States by Purdue Pharma LP. ELI-216 utilizes the Company's abuse-deterrent technology that is based on a pharmacological approach. ELI-216 is a combination of a narcotic agonist, oxycodone hydrochloride, in a sustained-release formulation intended for use in patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulat! ed to deter abuse of the drug. Products utilizing the pharmacological approach to deter abuse such as Suboxone, a product marketed in the United States by Reckitt Benckiser Pharmaceuticals, Inc., and Embeda, a product marketed in the United States by Pfizer, have been approved by the United States Food & Drug Administration (FDA). ELI-216 demonstrates a euphoria-blocking effect when the product is crushed. Elite has developed ELI-154 and ELI-216 and retains the rights to these products.
The Company competes with Collegium Pharmaceuticals, Inc., Purdue Pharma LP, Acura Pharmaceuticals, Inc., Durect Corporation, Mylan Laboratories, Inc., Par Pharmaceuticals, Inc., Alkermes, Inc., Teva Pharmaceuticals Industries Ltd., Aptalis Pharma, Impax Laboratories, Inc., and Watson Pharmaceuticals.
Advisors' Opinion:- [By CRWE]
Today, ELTP has shed (-8.01%) down -0.009 at $.101 with 4,629,899 shares in play thus far (ref. google finance Delayed: 1:00PM EDT September 16, 2013).
Elite Pharmaceuticals, Inc. previously reported the first quarter of fiscal year 2014 ended June 30, 2013. Manufacturing and profit split revenues comprised almost all of Elite’s quarterly revenues and totaled $717k for the quarter, an increase of 41% from the prior year. This growth is attributed to the launch of two new products during the quarter, Phentermine 15mg and 30mg capsules, combined with strong year-on-year growth of the Elite’s Hydromorphone 8mg tablets and contract manufactured Methadone 10mg product lines.
- [By James E. Brumley]
Exactly one month ago today I penned some bullish thoughts on Elite Pharmaceuticals Inc. (OTCBB:ELTP). If you're familiar with the company - or a regular reader of this site - then you may know why that sounds a little "off." See, at the time, ELTP shares were falling rather quickly, giving up all the gains they had made just a few days before. Almost needless to say, my premise was not a well received one. Let's just say I received some "colorful disagreements" by being optimistic about the biopharma company.
- [By James E. Brumley]
Judging from the company it's keeping Green Automotive Co. (OTCMKTS:GACR) may have just made its way into the upper echelon of small cap stock opportunities. The electric car company joins Elite Pharmaceuticals Inc. (OTCBB:ELTP), Amarantus Bioscience Holdings, Inc. (OTCBB:AMBS), and only three other companies as Wall-Street.com's "Best 6 Stocks" for January of 2014. As one of the top information resources for investors - particularly in terms of information regarding small and micro cap stocks - being named among the site's top pick is an accolade for AMBS, ELTP, and GACR. Even more impressive is that Green Automotive Co. was the only consumer-goods name among those six. Amarantus Bioscience Holdings and Elite Pharmaceuticals are biotechnology names... an industry that can and often does attract a lot of attention just by the nature of the business. The other three names making the "Best 6" list were an energy explorer, a power-management technology manufacturer, and prescription/medical food producer. For an electric car manufacturer to make the list speaks quite highly of GACR.
Top 10 Safest Stocks To Watch For 2015: WageWorks Inc (WAGE)
WageWorks, Inc., incorporated on January 28, 2000, is an on-demand provider of tax-advantaged programs for consumer-directed health, commuter and other employee spending account benefits (CDBs), in the United States. The Company administers and operates a broad array of CDBs, including spending account management programs such as health and dependent care Flexible Spending Accounts (FSAs), Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs), and commuter benefits, such as transit and parking programs. The Company delivers its CDB programs through a scalable delivery model that employer clients and their employee participants may access through a standard Web browser on any Internet-enabled device, including computers, smart phones and other mobile devices such as tablet computers. In January 2013, the Company acquired Benefit Concepts, Inc.
The Company focuses on providing CDB programs to employer clients of any size. It provides marketing programs that are designed to maxmize employee participation in its employer clients��CDB offerings. The Company markets and sells its CDB programs through multiple channels, including direct sales to enterprises, direct sales and through brokers to small and medium-sized businesses (SMBs), and direct sales to industry purchasing and affiliate groups and through channel partners.
Its SMB distribution channel complements its enterprise sales channel and consists of third party advisors, including insurance agents and benefits consultants who typically have two to three enterprise clients and several hundred smaller employer clients, and institutional resellers, including regional and national insurance carriers, health plans, payroll providers, commercial banks and third-party administrators (TPAs). The Company also sells its programs through group purchasing organizations in which the Company negotiate a standard service contract with group purchasing organizations that are formed by industry specific employers to cov! er their members.
The Company competes with TASC, Inc, Aetna, UHC, Aon Hewitt, ADP, Ceridian, CDBs and Bank of America.
Advisors' Opinion:- [By John Udovich]
On Wednesday, small cap employee flexible spending account facilitator Wageworks Inc (NYSE: WAGE) rose 12.22% despite a secondary offering that effectively rewarded insiders plus the stock has tripled since last March. However, Wageworks��CEO recently said in a�conference call last week that he believes the�private health care exchanges related to Obamacare are expanding�the company���market plus WAGE also raised its forecast for full-year growth. So�does that make this small cap a buy?�
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on WageWorks (NYSE: WAGE ) , whose recent revenue and earnings are plotted below. - [By Laura Brodbeck]
Tuesday
Earnings Expected From: Frontier Communications Corporation (NASDAQ: FTR), GSI Group, Inc. (GSIG), Tesla Motors, Inc. (NASDAQ: TSLA), WageWorks, Inc. (NYSE: WAGE), DIRECTV (NASDAQ: DTV), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Economic Releases Expected: �Australian trade balance, New Zealand�� unemployment rate, Canadian trade balance, eurozone PPI, British services PMIWednesday
Top 10 Safest Stocks To Watch For 2015: National-Oilwell Inc.(NOV)
National Oilwell Varco, Inc. designs, constructs, manufactures, and sells systems, components, and products used in oil and gas drilling and production; provides oilfield services and supplies; and distributes products, and provides supply chain integration services to the upstream oil and gas industry worldwide. Its Rig Technology segment offers offshore and onshore drilling rigs; derricks; pipe lifting, racking, rotating, and assembly systems; rig instrumentation systems; coiled tubing equipment and pressure pumping units; well workover rigs; wireline winches; wireline trucks; cranes; and turret mooring systems and other products for floating production, storage and offloading vessels, and other offshore vessels and terminals. The company?s Petroleum Services & Supplies segment provides various consumable goods and services to drill, complete, remediate, and workover oil and gas wells and service pipelines, flowlines, and other oilfield tubular goods. It also manufacture s, rents, and sells products and equipment for drilling operations, including drill pipe, wired drill pipe, transfer pumps, solids control systems, drilling motors, drilling fluids, drill bits, reamers and other downhole tools, and mud pump consumables. In addition, this segment provides oilfield tubular services comprising the provision of inspection and internal coating services; equipment for drill pipe, line pipe, tubing, casing, and pipelines; and coiled tubing pipes and composite pipes. Its Distribution Services segment sells maintenance, repair and operating supplies, and spare parts to drill site and production locations. The company primarily serves drilling contractors, shipyards and other rig fabricators, well servicing companies, pressure pumping companies, oil and gas companies, supply stores, and pipe-running service providers. National Oilwell Varco, Inc. was founded in 1862 and is based in Houston, Texas.
Advisors' Opinion:- [By Shauna O'Brien]
Jefferies reported on Monday that it has lifted its price target on National-Oilwell Varco, Inc. (NOV).
The firm has reaffirmed a “Buy” rating on NOV, and has raised the company’s price target from $84 to $91. This price target suggests a 14% increase from the stock’s current price of $78.24.
Analyst Brad Handler noted that NOV’s weak margin will likely rebound in 2014 and the chances of a dividend increase are high.
Looking forward, the firm has lifted its order estimates for FY2013 from $10.8 billion to $11.3 billion. FY2014 earnings estimates have been raised from $6.40 to $6.50 per share and FY2015 estimates have been increased from $7.65 to $7.95 per share.
National-Oilwell Varco shares were up 76 cents, or 0.97% during pre-market trading Monday. The stock is up 14% YTD.
- [By John Divine]
Of course, when the demand for energy is in question, companies that supply drilling equipment, like National Oilwell Varco (NYSE: NOV ) , suffer, as well. Shares lost 1.7% today as a result of the declining price of oil. The more oil exploration companies ��like EOG Resources ��can get for a barrel of their wares, the more they'll need the equipment needed to extract those extra profits from the ground. Although these businesses will always be somewhat beholden to global energy markets, you still have to excel at what you do to grow sales by 36%, as National Oilwell Varco did in 2012.
- [By WALLSTCHEATSHEET]
National Oilwell Varco provides equipment and components for oil and gas drilling and production; oilfield services; and supply chain integration services to the upstream oil and gas industry worldwide. The company�announced that it would begin to explore the possibility of spinning off its distribution business from the rest of its operations. The stock has been surging higher in recent quarters and is currently trading near highs. Over the last four quarters, earnings have been mixed while revenue figures have been rising, which has left investors with conflicting feelings about earnings announcements. Relative to its peers and sector,�National Oilwell Varco has been an average performer year-to-date. Look for�National Oilwell Varco to OUTPERFORM.
Top 10 Safest Stocks To Watch For 2015: Repros Therapeutics Inc.(RPRX)
Repros Therapeutics Inc., a development stage biopharmaceutical company, focused on the development of new drugs to treat hormonal and reproductive system disorders. It is developing Androxal, an oral therapy that normalizes testicular function for the treatment of low testosterone due to secondary hypogonadism. The company is also conducting a phase 2 study of the use of Androxal in the treatment of type 2 diabetes in hypogonadal men. In addition, it is developing Proellex, an orally administered selective blocker of the progesterone receptor in women for the treatment of uterine fibroids and endometriosis; and phentolamine-based product candidate VASOMAX for the treatment of male erectile dysfunction. The company was formerly known as Zonagen, Inc. and changed its name to Repros Therapeutics, Inc. in May 2006. Repros Therapeutics, Inc. was founded in 1987 and is based in The Woodlands, Texas.
Advisors' Opinion:- [By John Udovich]
On Friday, small cap pharma stock Apricus Biosciences Inc (NASDAQ: APRI) jumped just over 10% and not only�did the stock hold onto those gains, it made�another 10% jumps on Monday���meaning its time to take a closer look at the stock along with the performance of other potential benchmarks in the sexual health or reproductive health spaces like The Female Health Company (NASDAQ: FHCO) and Repros Therapeutics Inc (NASDAQ: RPRX).
- [By Rich Bieglmeier]
In the movie business, they call this foreshadowing. You would have made a killing if you did nothing else but ride piggy-back when Repros Therapeutics Inc.'s (RPRX) Ms. Katherine A. Anderson opened the checkbook. She might not be a big buyer, but whoa, it's no doubt that the CPA and Chief Financial Officer, Chief Accounting Officer and Secretary knows how to work the numbers.
- [By Monica Gerson]
Repros Therapeutics (NASDAQ: RPRX) shares climbed 13.42% to $27.05. The volume of Repros Therapeutics shares traded was 319% higher than normal. Repros shares have jumped 54.77% over the past 52 weeks, while the S&P 500 index has gained 16.68% in the same period.
- [By Jake L'Ecuyer]
Equities Trading UP
Repros Therapeutics (NASDAQ: RPRX) shot up 29.82 percent to $27.60 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal庐. Shares of Kythera Biopharmaceuticals (NASDAQ: KYTH) got a boost, shooting up 26.04 percent to $42.26 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat. Aeropostale (NYSE: ARO) was also up, gaining 16.75 percent to $10.05 after private equity firm Sycamore Partners reported that it had bought a 7.96 percent stake in the company.
Top 10 Safest Stocks To Watch For 2015: Dj Wilshire Reit Etf (RWR)
SPDR DJ Wilshire REIT (the Fund), formerly DJ Wilshire REIT ETF, seeks to replicate as closely as possible the performance of the Dow Jones Wilshire REIT Index (the Index). The Fund utilizes a passive or indexing approach, and attempts to approximate the investment performance of its Index, by investing in a portfolio of stocks to replicate the Index. The Index seeks to provide an effective representation of the United States real estate investment trust (REIT) market.
The Index consists of companies whose charters are the equity ownership and operation of commercial real estate, and which operate under the REIT Act of 1960. The Index is generally rebalanced monthly. Companies are chosen based upon market capitalization, source of revenue and liquidity. Each REIT in the Index is weighted by its float-adjusted market capitalization. The Fund�� investment manager is SSgA Funds Management, Inc.
Advisors' Opinion:- [By Chuck Saletta]
Where to invest?
Domestic stocks. The Vanguard Total Market (NYSEMKT: VTI ) ETF is a one-stop-shop that gives you access to around 99.5% by market cap of the publicly held U.S. stocks traded on major exchanges. A mere 3% turnover and microscopically low 0.05% expense ratio makes this a low-cost way to invest in the overall stock market. Investment-grade bonds. The iShares iBoxx $Invest Grade Corp Bond � (NYSEMKT: LQD ) ETF owns nearly $24 billion worth of investment-grade corporate bonds. A small 4% turnover and low 0.15% expense ratio make this a low-cost way to get bond exposure. Real estate. The SPDR Dow Jones REIT (NYSEMKT: RWR ) ETF has a bit over $2 billion invested in real estate investment trusts, attempting to match the Dow Jones Select REIT index. With a reasonable 7% turnover and a still pretty low 0.25% expense ratio, this is a reasonable way to get real estate exposure without turning yourself into a landlord. Foreign stocks. Vanguard's Total International Stock Index (NASDAQ: VXUS ) ETF has nearly $90 billion in foreign stocks under its control, owning pieces of more than 6,100 stocks from 45 countries. With a mere 3% turnover and low 0.16% expense ratio, it's one of the lowest-cost ways to get your hands on foreign companies without being an international accounting expert. Inflation-protected government bonds. The iShares Barclays TIPS Bond (NYSEMKT: TIP ) ETF has around $20 billion invested in U.S. Treasury inflation-protected bonds. With a low expense ratio of 0.2% and a reasonable 10% turnover rate, it's a decent way to get exposure to inflation-protected bonds. Note, though, that
There are countless possibilities for building your retirement portfolio to cover Social Security's gap, depending on your personal risk tolerance, timeline, and need for cash. Here are decent index-style ETFs across various asset types to consider when building your plan: - [By Hilary Kramer]
2. Real Estate Investment Trusts (REITs) The REIT is another alternative vehicle that's gone mainstream in recent years. Hundreds of broad-based and specialized real estate companies and ETFs are available, and after a correction a few months ago, many are on the cheap side. Like any other alternative, this should be a seasoning for your portfolio and not the sauce itself. For most retail investors, a stake in an indexed fund like the SPDR Dow Jones REIT (NYSE: RWR) should be more than adequate, or look into the companies that provide services to the REIT industry like HFF (NYSE: HF) and Jones Lang LaSalle (NYSE: JLL).
Top 10 Safest Stocks To Watch For 2015: Community Health Systems Inc (CYH)
Community Health Systems, Inc., incorporated on June 6, 1996, is an operator of hospitals in the United States. The Company provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets throughout the United States. As of December 31, 2012, the Company owned or leased 135 hospitals, Consisting of 131 general acute care hospitals and four standalone rehabilitation or psychiatric hospitals. These hospitals are geographically diversified across 29 states, with an aggregate of 20,334 licensed beds. The Company provides a range of general and specialized hospital healthcare services and other outpatient services to patients in the communities in which the Company are located. Services provided through its hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. On March 1, 2012, the Company acquired MetroSouth Medical Center in Blue Island, Illinois. On July 1, 2012, the Company�� subsidiaries acquired all of the assets of Memorial Health Systems in York, Pennsylvania.
Effective January 1, 2012, the Company completed the acquisition of Moses Taylor Healthcare System based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals and other healthcare providers. This healthcare system includes Moses Taylor Hospital (217 licensed beds) located in Scranton, Pennsylvania, and Mid-Valley Hospital (25 licensed beds) located in Peckville, Pennsylvania. Effective March 5, 2012, the Company completed a merger with Diagnostic Clinic of Longview, P.A., which is a multi-specialty clinic serving residents of Longview, Texas and surrounding East Texas communities. This healthcare system includes Memorial Hospital (100 licensed beds), the Surgical Center of York, and other outpatient and ancillary services.
The Company provides outpatient services at urg! ent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers and home health and hospice agencies. In addition to its hospitals and related businesses, the Company also own and operate 64 licensed home care agencies and 31 licensed hospice agencies, located primarily in markets where the Company also operate a hospital. Also, through its wholly owned subsidiary, Quorum Health Resources, LLC, or QHR, the Company provides management and consulting services to non-affiliated general acute care hospitals located throughout the United States.
Advisors' Opinion:- [By Keith Speights]
Meanwhile, the second-largest hospital chain, Community Health Systems (NYSE: CYH ) , saw its shares rise nearly 4%. This increase translates to a higher market cap of more than $150 million.
- [By Keith Speights]
The stock market clearly agreed. Immediately after the Supreme Court decision, hospital stocks surged. Community Health Systems (NYSE: CYH ) jumped 8%. Health Management Associates (NYSE: HMA ) shares rose 7%. The largest private hospital chain, HCA Holdings (NYSE: HCA ) , soared by 10%.
- [By Lauren Pollock]
Health Management’s new board urged shareholders to approve the hospital operator’s roughly $3.9 billion deal to be acquired by peer Community Health Systems Inc.(CYH) after completing a review, and the company also reported swinging to a third-quarter loss.
- [By Keith Speights]
If we were to draw two columns -- one for winners from the Patient Protection and Affordable Care Act, or PPACA, and another for losers -- the word "hospitals" would probably be listed near the top in the winner's column. Large hospital chains Health Management Association (NYSE: HMA ) and Tenet Healthcare (NYSE: THC ) , have seen their stocks more than double over the past year, while Community Health Systems (NYSE: CYH ) is up around 75%.
Top 10 Safest Stocks To Watch For 2015: Berkshire Bancorp Inc.(BERK)
Berkshire Bancorp Inc. operates as the bank holding company for The Berkshire Bank that provides community banking services to businesses, professionals, and retail customers primarily in New York City metropolitan area and the Villages of Goshen and Harriman. The company offers various deposit products, including statement savings accounts, NOW accounts, money market deposits accounts, checking accounts, time deposits, and certificates of deposit. Its loan portfolio comprises commercial mortgage loans secured by office buildings, retail establishments, multi-family residential real estate, and other types of commercial property; commercial loans to businesses for inventory financing, working capital, machinery and equipment purchases, expansion, and other business purposes; and residential mortgage loans secured by first liens on one-to-four family owner-occupied or rental residential real estate, as well as residential single family construction, home equity, and short-t erm fixed-rate consumer loans. Berkshire Bancorp Inc. also offers title insurance agency services. The company operates seven deposit-taking offices in New York City; four deposit-taking offices in Orange and Sullivan Counties, New York; one deposit taking office in Ridgefield, New Jersey; and one deposit taking office in Teaneck, New Jersey. The company was founded in 1979 and is based in New York, New York.
Advisors' Opinion:- [By Tim Melvin]
One interesting bank that is seeing insider buying activity is Berkshire Bancorp (BERK). The company has recently switched from the Nasdaq to OTC markets, but that has not stopped director Moses Marx from consistently buying BERK stock. Berkshire does business in the already overbanked New York and New Jersey markets, and the stock is very cheap at just 82% of book value. Insiders won more than 60% of the bank, so investors are on the same side of the table as management.
